"This retrospective cohort study found that taking GLP-1RAs was associated with a reduced overall risk of cancer, including ...

(Reuters) -Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney ...

Over 1,800 lawsuits claim Ozempic caused stomach paralysis, vision loss, and more. Read what’s next in the legal fight.

Canada's health regulator has approved Novo Nordisk's diabetes drug, Ozempic, for reducing the risk of kidney failure and ...

GLP-1 receptor agonist medications like Ozempic have been talked about so much that its side effects (like nausea and ...

Women using Ozempic and similar drugs are reporting changes in the vulva area, termed 'Ozempic vulva,' including sagging, dryness, and muscle weakness ...

The viral weight-loss GLP-1 injection is now in the dock with $2 billion lawsuits as patients allege stomach paralysis, ...

Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...

The Ministry of Health issued a nationwide alert warning Kenyans against misusing Semaglutide, a diabetes drug marketed under ...

An international clinical trail showed the risk of kidneys deteriorating or failing was lower in patients taking Ozempic, as ...

Ozempic and other GLP-1 drugs have become extremely popular for their ability to manage Type 2 diabetes symptoms and spur ...